title: [Verteporfin and photosensitivity in diabetic].
abstract: OBJECTIVE
  A 33-year-old woman with a myopic neovascular lesion was treated with photodynamic therapy (PDT) with verteporfin. She had a borde-line diabetes mellitus that finally needed treatment with a sulfonylurea. She underwent a second treatment with PDT that was uneventful, but 10 hours later she experienced severe skin photosensitivity reaction.
  
  
  CONCLUSIONS
  As the use of verteporfin becomes more widespread around the world, physicians must be alert to the possibility of adverse side effects associated with its use and its interaction with other drugs.
authors.affiliation: Hospital General, Medina del Campo, Valladolid, España.
authors.forename: V M
authors.initials: VM
authors.lastname: Asensio Sánchez
authors.forename: A
authors.initials: A
authors.lastname: Corral Azor
authors.forename: A
authors.initials: A
authors.lastname: García Pascual
mesh_terms: D000328:Adult; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D017484:Dermatitis, Phototoxic / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000628:therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D009216:Myopia / Q000150:complications; D010778:Photochemotherapy / Q000009:adverse effects*; D017319:Photosensitizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D011166:Porphyrins / Q000009:adverse effects* / Q000627:therapeutic use; D000077362:Verteporfin
chemical_list: D007004:Hypoglycemic Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin